Please sign in to follow a disease.
New study tests how a common sedative changes brain activity during surgery
NCT ID NCT07259460
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how the drug dexmedetomidine, given through a precise infusion pump, affects brain wave monitors and pain sensors in 60 adults undergoing general anesthesia with propofol and remifentanil. Researchers want to see if changes in dexmedetomidine levels alter the Patient State Index, EEG patterns, and the Analgesia Nociception Index. The goal is to improve how doctors monitor sedation and pain during surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dexmedetomidine
- What this could lead to
- If successful, this could help anesthesiologists better adjust sedation and pain control during surgery, potentially improving patient safety and recovery.
- What could go wrong
- This is a small, early-phase observational study with only 60 participants. It does not test a new treatment or cure, so results may not change clinical practice directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2025
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Women undergoing brast cancer surgery with general anesthesia with Propofol, remifentanil and Dexmedetomidine TCI will be recruited
- Ages
-
18 to 80 years
- Sex
-
Female participants only
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Undergo general anaesthesia with Targeted Controlled Infusion of Propofol and Rmifntanil (Eleveld model) and Dexmedetomidine (Dyck model) Exclusion Criteria: * Neurological disease * Psychiatric disease * Obesity * Regional anesthesia performed
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Adjuvants, anesthesia are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Treviso Regional Hospital
RECRUITINGTreviso, TV, 31100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.